5-HT6 receptor antagonists: potential efficacy for the treatment of cognitive impairment in schizophrenia

N MWJ de Bruin, CG Kruse - Current Pharmaceutical Design, 2015 - ingentaconnect.com
5-hydroxytryptamine6 receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …
被引用次数：67 相关文章

5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

NMWJ de Bruin, CG Kruse - Current pharmaceutical …, 2015 - pubmed.ncbi.nlm.nih.gov
5-hydroxytryptamine6 receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …

5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia.

NM de Bruin, CG Kruse - Current Pharmaceutical Design, 2015 - europepmc.org
5-hydroxytryptamine6 receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …

5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

N de Bruin, CG Kruse - Current Pharmaceutical Design, 2015 - hero.epa.gov
hydroxytryptamine6 receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …
[PDF] academia.edu

[PDF][PDF] 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

NMWJ de Bruin, CG Kruse - Current Pharmaceutical Design, 2015 - academia.edu
5-hydroxytryptamine6 receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …

5-HT6 receptor antagonists: Potential efficacy for the treatment of cognitive impairment in schizophrenia

N de Bruin, CG Kruse - 2015 - publica.fraunhofer.de
hydroxytryptamine (6) receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …

5-HT6 receptor antagonists: Potential efficacy for the treatment of cognitive impairment in schizophrenia

N de Bruin, CG Kruse - 2015 - publica.fraunhofer.de
hydroxytryptamine (6) receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …